Aion Therapeutic Provides Default Status Update investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
July 27, 2021
The Inaugural staging of CanEx Psychedelics Summit was hosted at the Jewel Grande Montego Bay Resort in Montego Bay, St. James, Jamaica from July 15-16.
Trinidadian-born Douglas Gordon, Founder of CanEx Jamaica and CEO of Silo Wellness – a vertical Mushroom company that grows its mushroom in Jamaica – said that he felt it necessary for the discussion surrounding the emerging industry needed to start in Jamaica.
Jamaica is one of the few places where producing magic mushrooms is still legal and is also one of two locations – the other being Oregon- where Silo Wellness hosts its mushroom retreats.
Psychedelics are a class of hallucinogenic substances that produce changes in perception, mood, and cognitive processes of which include magic mushrooms otherwise known as Psilocybin Mushrooms. Researchers say extracts from mushrooms have a strong track record in treating psychiatric and psychosomatic illnesses.
Aion Therapeutic Combines the Healing Powers of Cannabinoids and Psychedelics to Treat Cancer and Depression benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Apollon Formularies Plc (AQSE: APOL) ( Apollon or the Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange is pleased to announce that its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate cancer cells in 3D cell cultures in third party independent laboratory testing. ¹ This finding is in addition to the results recently announced on May 18, 2021² that Apollon formulations were successful in killing HER2+ breast cancer cells, and the announcement on June 28, 2021³ that Apollon formulations were successful in killing triple-negative breast cancer cells. This testing was performed under a joint testing agreement with Aion Therapeutic Inc. (CSE: AION) ( Aion ),a BC based international pharmaceutical company trading on the Canadian Securities Exchange.
Apollon Formularies (AQSE:APOL) | RNS | Apollon Formularies - Apollon Formulations Kill Prostate Cancer Cells proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.